Alzheimer’s Disease: Where Do We Stand Now? - 0513-0000-17-077-H01-P

Alzheimer’s Disease: Where Do We Stand Now?

by Trisha Bogucki, PharmD and Esther Kim, PharmD
0513-0000-17-077-H01-P
(4.5 / 0 ratings )

This course is credentialed for:
Pharmacy (2.00 Contact Hr)

ONLINE
Price: $24.00
CE-PRO Price: $12.00

Summary:

The treatment approach to managing patients with dementia caused by Alzheimer’s disease (AD) is only through symptom control. The pathophysiology is not entirely known, and there is no drug available to prevent or cure the disorder. All FDA-approved drugs work by modulating neurotransmitters, either acetylcholine or glutamate. The two basic classes of drugs used to manage symptoms of AD are acetylcholinesterase inhibitors (AcHEI) and partial N-methyl-D-aspartate (NMDA) receptor antagonists. In addition, medications to control mood and behavior are used. These drugs are used to relieve depression, agitation, and insomnia, and include antidepressants, neuroleptics, anxiolytics, and anticonvulsants. As more research is completed and data collected, possible links to genetics, nutrition, and chemical entities may provide insight into future modes of therapy.

Objectives:

The goal of this dementia caused by Alzheimer’s disease (AD) continuing education program is to provide pharmacists and physicians with knowledge about the clinical aspects of managing patients with AD. After studying the information presented here, you will be able to:
  • Describe the approved drugs used to treat patients with AD
  • List the available drug treatments for secondary features of AD
  • Discuss supplements and nonpharmacologic interventions used in managing symptoms of AD
  • Review emerging therapies and areas of research for AD
 

 
Accreditation Information
 
This course is intended for multiple professions, including pharmacists, pharmacy techs, and physicians.
 
Pharmacists: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at ContinuingEducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com and search for this topic title.
 
OnCourse Learning is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Pharmacy (provider # 50-1489).
 
Type of Activity: Knowledge
 
Initial Release Date: 03/27/2017; Planned Expiration Date: 03/27/2020

Course Originally Released on: 1/16/2013
Date of Most Recent Review: 12/28/2016
Course Termination/Update Date: 3/27/2020

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

 

For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

Sort By
Brock B - AURORA, CO  ·  Apr 19, 2017
Great review of the medications for treating Alzheimer's Disease.
Was this review helpful?  0
 
ONLINE
Price: $24.00
CE-PRO Price: $12.00